Live Analyst Rating Changes 20533 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Pito Chickering
DB

Pito Chickering

Deutsche Bank
Wall Street Analyst
★★★★☆
#529
on 13Foresight · ranked by our own returns
76%
Success Rate
+5.1%
Average Return
28 of 37 calls profitable · -5.1% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 76% of Pito Chickering's ratings turned a profit when each position was held for 1 year — averaging +5.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

18 Buy 15 Hold 0 Sell
Pito's Stock Coverage 26 ratings · 2026-08-08
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
ZBH
Zimmer Biomet Holdings
 Aug 06, 2026 HOLD Buy
+17.4% avg upside
38 analysts
$98.00
1.58% Upside
 -0.7% ·
MDLN
Medline
 Aug 06, 2026 HOLD Strong Buy
+37.3% avg upside
27 analysts
$37.00
5.02% Upside
 +2.1% ·
MD
Pediatrix Medical Group
 Aug 05, 2026 HOLD Buy
-17.6% avg upside
14 analysts
$25.00
7.75% Downside
 +4.2% ·
DVA
DaVita
 Aug 05, 2026 BUY Buy
-6.3% avg upside
17 analysts
$265.00
44.17% Upside
 -2.6% ·
BTSG
BrightSpring Health Services, Inc.
 Aug 03, 2026 BUY Strong Buy
+6.0% avg upside
20 analysts
$70.00
12.22% Upside
 +3.2% ·
BAX
Baxter International
 Jul 31, 2026 HOLD Buy
+21.8% avg upside
23 analysts
$27.00
2.08% Downside
 +3.2% ·
LH
Labcorp Holdings
 Jul 31, 2026 HOLD Strong Buy
-15.2% avg upside
37 analysts
$306.00
4.08% Downside
 +1.5% ·
BSX
Boston Scientific
 Jul 30, 2026 BUY Strong Buy
+37.4% avg upside
38 analysts
$60.00
21.64% Upside
 +7.2% ·
OPCH
Option Care Health
 Jul 30, 2026 HOLD Strong Buy
+23.3% avg upside
20 analysts
$24.00
0.93% Upside
 +4.6% ·
HCA
HCA Healthcare
 Jul 27, 2026 BUY Buy
-2.1% avg upside
36 analysts
$476.00
15.13% Upside
 +6.1% ·
ACHC
Acadia Healthcare
 May 01, 2026 BUY Strong Buy
+32.7% avg upside
17 analysts
$32.00
1.40% Upside
 +16.8% ·
SYK
Stryker
 May 01, 2026 HOLD Strong Buy
+8.8% avg upside
37 analysts
$315.00
7.07% Downside
 +15.3% ·
BLCO
Bausch + Lomb Corporation
 Apr 30, 2026 HOLD Buy
+19.7% avg upside
19 analysts
$16.00
4.69% Downside
 +4.8% ·
MMED
MiniMed Group, Inc.
 Mar 31, 2026 BUY Strong Buy
+12.2% avg upside
14 analysts
$20.00
2.11% Upside
 +31.4% ·
AHCO
AdaptHealth
 Feb 25, 2026 HOLD Strong Buy
+106.3% avg upside
13 analysts
$9.50
66.98% Upside
 -39.0% ·
LMRI
Lumexa Imaging Holdings, Inc.
 Jan 05, 2026 BUY Strong Buy
+61.9% avg upside
8 analysts
$22.00
89.95% Upside
 -31.2% ·
AVAH
Aveanna Healthcare Holdings
 Sep 15, 2025 BUY Buy
-1.2% avg upside
18 analysts
$11.50
21.26% Upside
 +13.1% ·
EW
Edwards Lifesciences
 Jul 25, 2025 BUY Strong Buy
+12.1% avg upside
34 analysts
$94.00
4.86% Upside
 +3.3% ·
DGX
Quest Diagnostics
 Jul 23, 2025 HOLD Buy
-23.0% avg upside
34 analysts
$178.00
25.29% Downside
 +36.0% ·
DCGO
DocGo
 Feb 28, 2025 HOLD Buy
+331.4% avg upside
7 analysts
$2.85
349.39% Upside
 -76.8% ·
PEN
Penumbra
 Oct 31, 2024 BUY Buy
+1.8% avg upside
23 analysts
$241.00
25.79% Downside
 -0.7% ·
UHS
Universal Health
 Oct 28, 2024 BUY Buy
+14.4% avg upside
22 analysts
$240.00
38.32% Upside
 +7.7% ·
MDT
Medtronic
 Aug 20, 2024 HOLD Buy
+10.9% avg upside
38 analysts
$85.00
2.53% Downside
 +12.8% ·
EHC
Encompass Health
 Aug 07, 2024 BUY Strong Buy
-11.0% avg upside
22 analysts
$95.00
24.12% Downside
 +38.0% ·
THC
Tenet Healthcare
 Jul 24, 2024 BUY Strong Buy
-10.3% avg upside
27 analysts
$155.00
40.81% Downside
 +2.1% ·
ACAD
ACADIA Pharmaceuticals
 Apr 19, 2021 HOLD Strong Buy
+25.1% avg upside
43 analysts
$62.00
112.34% Upside
 +4.8% ·
🔒 21 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Pito Chickering — Frequently Asked Questions
How accurate are Pito Chickering's stock ratings?
Based on the calls 13Foresight could measure, about 78% of Pito's ratings were profitable over a one-year hold, with an average return of +6.0% per rating, or -4.4% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Pito ranked on 13Foresight?
Pito Chickering is currently ranked #529 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Pito cover?
Pito most recently has ratings on ZBH, MDLN, MD, DVA, BTSG, BAX, LH, BSX, OPCH, HCA, ACHC, SYK and 14 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.